JA

Jesal Agarwal

Active Director Director DIN 06986253
DIN 06986253 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Sep 2014
Shareholding value •••• Premium profile

About Jesal Agarwal

Data last updated:

Jesal Agarwal is a Director at Aurigene Pharmaceutical Services Limited (since 2024), Nominee Director at Dres Energy Private Limited (since 2024) and Additional Director at Dr. Reddy's Bio-Sciences Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Environment and Chemicals and Materials. The 4 current companies with reported revenue have a combined latest revenue of ₹660 Cr; the largest is Aurigene Pharmaceutical Services Limited at ₹645 Cr (FY 2025). Earlier, Jesal Agarwal was an Alternate Director at Medtronic Engineering And Innovation Center Private Limited (2014–2016).

DIN 06986253
Primary Designation Director
Industry Pharma
First Appointment 29 Sep 2014
Oldest Company Age 26 yrs
Largest company Aurigene Pharmaceutical Services Limited · ₹645 Cr (FY 2025)
Combined revenue ₹660 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20242019₹645 Cr (FY 2025)Active
Dres Energy Private Limited U40104KA2015PTC083148
Nominee Director12 Jun 20242015₹14.09 Cr (FY 2025)Active
Dr. Reddy's Bio-Sciences Limited U72200TG2000PLC034765
Additional Director24 Nov 20252000₹1.20 Cr (FY 2025)Active
Dr. Reddy's Formulations Limited U24299TG2021PLC149527
Ceo04 Jul 20252021₹5.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alternate Director29 Sep 20142011₹667 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Jesal Agarwal

NameDINCompanyDesignation
Akhil RaviAurigene Pharmaceutical Services LimitedCeo
Atul Sachdeva07645130Aurigene Pharmaceutical Services LimitedCfo
Deepak Sapra08563727Aurigene Pharmaceutical Services LimitedDirector
Erez Israeli08563726Aurigene Pharmaceutical Services LimitedDirector
Mannam Venkata Narasimham02677423Aurigene Pharmaceutical Services Limited , Dr. Reddy's Formulations LimitedDirector
Sapna08434059Aurigene Pharmaceutical Services LimitedCompany Secretary
Abhishek GuptaDres Energy Private LimitedCfo
Amit Mallawat07898743Dres Energy Private LimitedDirector
Anchal SachdevDres Energy Private LimitedCompany Secretary
Ashok Pundalik Shintre10133558Dres Energy Private LimitedDirector
Saurabh KackerDres Energy Private LimitedCompany Secretary
Shanker Kumar Pathe10467620Dres Energy Private LimitedAdditional Director
Shyam Lal Sharma03136121Dres Energy Private LimitedDirector
Vikas Ramchandra Chomal03103192Dres Energy Private LimitedDirector
Vikas Saharan10829909Dres Energy Private LimitedAdditional Director
Ashok Kalyan TavvaDr. Reddy's Bio-Sciences LimitedCeo
Karishma SharmaDr. Reddy's Bio-Sciences LimitedCompany Secretary
Satish Reddy Kallam00129701Dr. Reddy's Bio-Sciences LimitedDirector
Seema Grover09784139Dr. Reddy's Bio-Sciences LimitedDirector
Vijay Kumar HurgatDr. Reddy's Bio-Sciences LimitedCfo
Manivannan Ganesh10631983Dr. Reddy's Formulations LimitedDirector
Mini PatniDr. Reddy's Formulations LimitedCompany Secretary
Sai Prasad ChennabathniDr. Reddy's Formulations LimitedCfo
Sanjay Sharma06938782Dr. Reddy's Formulations LimitedDirector

Directorship timeline

Open interactive timeline →
Dres Energy Private Limited
Dr. Reddy's Bio-Sciences Limited
Dr. Reddy's Formulations Limited
Aurigene Pharmaceutical Services Limited
Premium access

Shareholding and investment profile for Jesal Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jesal Agarwal

Jesal Agarwal currently holds 4 directorships: Aurigene Pharmaceutical Services Limited (Director, since 29 Mar 2024, revenue ₹645 Cr (FY 2025)); Dres Energy Private Limited (Nominee Director, since 12 Jun 2024, revenue ₹14.09 Cr (FY 2025)); Dr. Reddy's Bio-Sciences Limited (Additional Director, since 24 Nov 2025, revenue ₹1.20 Cr (FY 2025)); Dr. Reddy's Formulations Limited (Ceo, since 04 Jul 2025, revenue ₹5.3 Lakh (FY 2025)).

Jesal Agarwal was first appointed on 29 Sep 2014 as Alternate Director at Medtronic Engineering And Innovation Center Private Limited. The most recent appointment on record is 24 Nov 2025 at Dr. Reddy's Bio-Sciences Limited.

The 4 current companies of Jesal Agarwal that report revenue have a combined latest revenue of ₹660 Cr: Aurigene Pharmaceutical Services Limited ₹645 Cr (FY 2025); Dres Energy Private Limited ₹14.09 Cr (FY 2025); Dr. Reddy's Bio-Sciences Limited ₹1.20 Cr (FY 2025); Dr. Reddy's Formulations Limited ₹5.3 Lakh (FY 2025).

Jesal Agarwal held 1 earlier board appointment: Medtronic Engineering And Innovation Center Private Limited (Alternate Director, 29 Sep 2014 to 31 Mar 2016).

The current boards of Jesal Agarwal's companies include Akhil Ravi (Aurigene Pharmaceutical Services Limited), Atul Sachdeva (Aurigene Pharmaceutical Services Limited), Deepak Sapra (Aurigene Pharmaceutical Services Limited), Erez Israeli (Aurigene Pharmaceutical Services Limited), Mannam Venkata Narasimham (Aurigene Pharmaceutical Services Limited), Sapna (Aurigene Pharmaceutical Services Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available